FENORTHO (Sterling Knight Pharmaceuticals LLC)
Welcome to the PulseAid listing for the FENORTHO drug offered from Sterling Knight Pharmaceuticals LLC. This Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sterling Knight Pharmaceuticals LLC |
| NON-PROPRIETARY NAME: | FENORTHO |
| SUBSTANCE NAME: | FENOPROFEN CALCIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2017-03-21 |
| END MARKETING DATE: | 0000-00-00 |
FENORTHO HUMAN PRESCRIPTION DRUG Details:
| Item Description | FENORTHO from Sterling Knight Pharmaceuticals LLC |
| LABELER NAME: | Sterling Knight Pharmaceuticals LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2017-03-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69336-113_deb6dc29-c58d-4ee6-aa60-3a0436cc198a |
| PRODUCT NDC: | 69336-113 |
| APPLICATION NUMBER: | NDA017604 |
Other FENOPROFEN CALCIUM Pharmaceutical Manufacturers / Labelers:
